dr. A.J. van der Wekken

pulmonary oncologist

No picture available
E-mail:
a.j.van.der.wekken umcg.nl

Research

Publications
  1. An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

    Wei, J., Rybczynska, A. A., Meng, P., Terpstra, M., Saber, A., Sietzema, J., Timens, W., Schuuring, E., Hiltermann, T. J. N., Groen, H. J. M., van der Wekken, A. J., van den Berg, A. & Kok, K., 1-Oct-2020, In : Cancers. 12, 10, 17 p., 2843.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

    Paik, P. K., Felip, E., Veillon, R., Sakai, H., Cortot, A. B., Garassino, M. C., Mazieres, J., Viteri, S., Senellart, H., Van Meerbeeck, J., Raskin, J., Reinmuth, N., Conte, P., Kowalski, D., Cho, B. C., Patel, J. D., Horn, L., Griesinger, F., Han, J-Y., Kim, Y-C., Chang, G-C., Tsai, C-L., Yang, J. C-H., Chen, Y-M., Smit, E. F., van der Wekken, A. J., Kato, T., Juraeva, D., Stroh, C., Bruns, R., Straub, J., Johne, A., Scheele, J., Heymach, J. V. & Le, X., 29-May-2020, In : New England Journal of Medicine. 383, 10, p. 931-943 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (47) »

Press / Media
  1. Plasma testing

    Anthonie Wekken, van der

    15/11/2019

    1 Media contribution

    Press/Media: Expert CommentAcademic

  2. Longkanker in Perspectief

    Anthonie Wekken, van der

    05/11/2019

    1 Media contribution

    Press/Media: Expert CommentProfessional

  3. Oncologie longkanker special

    Anthonie Wekken, van der

    15/05/2019

    1 Media contribution

    Press/Media: Expert CommentProfessional

View all (6) »

Activities
  1. ALK treatment and resistance in NSCLC

    Anthonie Wekken, van der (Speaker)

    5-Feb-2020

    Activity: Talk or presentationAcademic

  2. ALK treatment and resistance in NSCLC

    Anthonie Wekken, van der (Speaker)

    4-Feb-2020

    Activity: Talk or presentationAcademic

  3. Treatment of mutations with TKI

    Anthonie Wekken, van der (Speaker)

    2-May-2019

    Activity: Talk or presentationProfessional

View all (12) »

ID: 35892471